# A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

> **NCT04116632** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 36 (actual)

## Conditions studied

- Obese But Otherwise Healthy Participants

## Interventions

- **DRUG:** BMS-963272
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04116632
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-30
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-02-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04116632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04116632, "A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04116632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*